Impact of Race and Ethnicity on Clinical Outcomes of Collagenase Clostridium histolyticum in Patients With Peyronie’s Disease Across Kaiser Permanente Southern California Database
The Permanente Journal · 2025
DOI: 10.7812/tpp/24.111 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Permanente Journal, 2025. Verfasst von Michael O Okene und 3 weiteren Autor:innen. Beteiligte Einrichtung: Kaiser Permanente Bernard J Tyson School of Medicine, Pasadena, CA, USA. Hauptthemen laut MEDLINE: Microbial Collagenase, Penile Induration. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
INTRODUCTION: Intralesional collagenase Clostridium histolyticum (CCH) injection is an effective intervention for treatment of Peyronie's disease (PD). While CCH efficacy has been demonstrated in White populations, little is known about treatment efficacy in Black and Hispanic populations. METHODS: This study examined efficacy of intralesional CCH in a racially diverse population in a large integrated health care system over 15 years. Treatment efficacy was defined as percent change in penile curvature abnormality from baseline after up to 4 treatment cycles. RESULTS: Of the 112 patients with PD who underwent CCH therapy, 66.1% of men were White, 22.3% were Hispanic, and 9.8% were Black. Additionally, 63.4% of men had a baseline penile curvature of 30°-59°. There were no significant differences in treatment response to CCH across different racial and ethnical groups (P = .96). There was a statistically significant difference in number of cycles completed across different ethnicities (P = .022). When adjusted for completing a full 4-cycle treatment, the Hispanic subgroup had the most patients complete fewer than 4 cycles (P = .0004). Almost half of the Hispanic subgroup (48%) reported needing an interpreter for health appointments. DISCUSSION: This is the largest postmarket analysis of CCH treatment outcomes in a racially diverse PD population. Though there were no significant differences in treatment outcomes by race and ethnicity, Hispanic men were significantly less likely to complete 4 cycles of injection therapy. One possible explanation is a language barrier, which prevented future follow-up treatment. CONCLUSION: The use of CCH treatment for PD is an effective option for racially diverse patient populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Kaiser Permanente Bernard J Tyson School of Medicine, Pasadena, CA, USA.
- Department of Urology, University of California San Diego, La Jolla, CA, USA.
- Department of Urology, Kaiser Permanente Baldwin Park Medical Center, Baldwin Park, CA, USA.
ORCID-Profile: Priyanka Achalu, Hossein Mirheydar
Zitieren
APA
Okene, M. O., Achalu, P., Hsieh, T. C., & Mirheydar, H. (2025). Impact of Race and Ethnicity on Clinical Outcomes of Collagenase Clostridium histolyticum in Patients With Peyronie’s Disease Across Kaiser Permanente Southern California Database. The Permanente Journal. https://doi.org/10.7812/tpp/24.111
Vancouver
Okene MO, Achalu P, Hsieh TC, Mirheydar H. Impact of Race and Ethnicity on Clinical Outcomes of Collagenase Clostridium histolyticum in Patients With Peyronie’s Disease Across Kaiser Permanente Southern California Database. The Permanente Journal. 2025. doi:10.7812/tpp/24.111
BibTeX
@article{Okene2025,
author = {Okene, Michael O and Achalu, Priyanka and Hsieh, Tung-Chin and Mirheydar, Hossein},
title = {Impact of Race and Ethnicity on Clinical Outcomes of Collagenase Clostridium histolyticum in Patients With Peyronie’s Disease Across Kaiser Permanente Southern California Database},
journal = {The Permanente Journal},
year = {2025},
doi = {10.7812/tpp/24.111}
}
EUVIMED